From the University of British Columbia School of Medicine, Vancouver, British Columbia, Canada.

ORCID: 0000-0002-5777-7836 (G.W.C.).

Correspondence: Geoffrey Cundiff, MD, FACOG, FACS, FRCSC. E-mail: [email protected].

The author has declared that he is the Chief Medical Officer for Amara Therapeutics.

The author has no sources of support to report.